HIGHLIGHTS
- who: P. Marzullo from the Department of Translational Medicine, Universitu00e0 del Piemonte Orientale, Via Solaroli, Novara, Italy have published the paper: Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients, in the Journal: (JOURNAL)
- what: The aim of this observational study was to expand the knowledge on OW semaglutide treatment in a real-world setting and to provide guidance on its efficacy on metabolic, anthropometric and hepato-renal outcomes in patients with T2D on other previous treatment schedules consecutively enrolled for up to 12 months.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.